In an exclusive with Drug Target Review, researchers at the University at Buffalo explain how they developed a novel peptide that could be a future treatment for chronic inflammatory pain.

Watch this on-demand webinar to learn how the two assays developed by Eurofins provide a more comprehensive pre-clinical model for cardiac liability assessment.

The UTX gene mutation was found to lead to an increased cancer risk, presenting a potential drug target for preventative therapies.

The team will receive $2 million over five years to investigate the CA2 brain region for the development of neurological therapies.

The intestine chip was infected with a coronavirus to test a variety of drugs, presenting a new method to investigate COVID-19 treatments.

The study showed that DNA “de-methylation” activity can be targeted to anywhere in the DNA and may be a new therapeutic strategy.

Researchers discovered that cardiovascular damage was caused by reduced microRNA-210 levels in patient cells and mice with type 2 diabetes.

In a pre-clinical study, fibrinogen increased the death of mouse brain neurons, suggeting fibrin can have similar toxic effects on neurons.

Cell Line Development and cell culture process teams, are you geared up to leverage the vast amount of data generated by high-throughput?

As interest in biotherapeutic proteins grows, the need to reduce cell line development costs and the time to market is more critical than ever.

Despite many companies considering digital transformation a top priority, research shows that 70% of digital transformation initiatives fail. In this ebook, we explore why and how the right approach can see your organisation succeed.

We discuss how liquid handling automation supports drug discovery workflows & highlight opportunities to improve the efficiency and quality of these.